When.com Web Search

  1. Ads

    related to: lipitor pfizer astellas 5 10 25 23 date

Search results

  1. Results From The WOW.Com Content Network
  2. Atorvastatin - Wikipedia

    en.wikipedia.org/wiki/Atorvastatin

    From 1996 to 2012, under the trade name Lipitor, atorvastatin became the world's best-selling medication of all time, with more than $125 billion in sales over approximately 14.5 years. [ 117 ] and $13 billion a year at its peak, [ 118 ] Lipitor alone "provided up to a quarter of Pfizer Inc.'s annual revenue for years."

  3. Cerivastatin - Wikipedia

    en.wikipedia.org/wiki/Cerivastatin

    Cerivastatin (INN, [1] brand names: Baycol, Lipobay) is a synthetic member of the class of statins used to lower cholesterol and prevent cardiovascular disease.It was marketed by the pharmaceutical company Bayer A.G. in the late 1990s, competing with Pfizer's highly successful atorvastatin (Lipitor).

  4. Torcetrapib - Wikipedia

    en.wikipedia.org/wiki/Torcetrapib

    Torcetrapib (CP-529,414, Pfizer) was a drug being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.Its development was halted in 2006 when phase III studies showed excessive all-cause mortality in the treatment group receiving a combination of atorvastatin (Lipitor) and torcetrapib.

  5. Lipitor? What Was That Again? - AOL

    www.aol.com/news/2012-07-31-lipitor-what-was...

    Pfizer (NYS: PFE) used to sell Lipitor exclusively in the United States. And it was a huge component of the company's revenue and earnings. Honest. I swear. You certainly wouldn't know it from the ...

  6. Pfizer Sues Merck to Block Lipitor/Zetia Combo Pill - AOL

    www.aol.com/2011/10/13/pfizer-sues-merck-to...

    But this time it's Pfizer (NYS: PFE) and Merck (NYS: Usually, it's a branded drugmaker fighting off a generics challenge from a copycat drugmaker. Pfizer Sues Merck to Block Lipitor/Zetia Combo Pill

  7. Pfizer's 3 Most Promising Drugs - AOL

    www.aol.com/news/2013-08-24-pfizers-3-most...

    Pfizer has been no stranger to the kind of damage that blockbuster drug patent expirations can inflict. The company's high-flying cholesterol fighter, Lipitor, has struggled since losing its ...